The latest quarterly R&D expense is $30.98 Million with a QoQ Growth of +67.72%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $30.98M.
$30.98M
$30.98 Million
Q2 FY2026 · 2026-06-30
+67.72%
vs. $18.47M prior quarter
14
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $30.98M | +67.72% | +74.82% |
| Q1 FY2026Period end 2026-03-31 | $18.47M | -6.51% | -17.55% |
| Q4 FY2025Period end 2025-12-31 | $19.76M | +2.54% | +29.80% |
| Q3 FY2025Period end 2025-09-30 | $19.27M | +8.72% | +15.07% |
| Q2 FY2025Period end 2025-06-30 | $17.72M | -20.89% | +23.12% |
| Q1 FY2025Period end 2025-03-31 | $22.41M | +47.18% | +102.78% |
| Q4 FY2024Period end 2024-12-31 | $15.22M | -9.10% | +97.01% |
| Q3 FY2024Period end 2024-09-30 | $16.75M | +16.33% | +84.58% |
| Q2 FY2024Period end 2024-06-30 | $14.40M | +30.29% | +122.37% |
| Q1 FY2024Period end 2024-03-31 | $11.05M | +42.99% | +110.06% |
| Q4 FY2023Period end 2023-12-31 | $7.73M | -14.84% | N/A |
| Q3 FY2023Period end 2023-09-30 | $9.07M | +40.15% | N/A |
| Q2 FY2023Period end 2023-06-30 | $6.47M | +23.08% | N/A |
| Q1 FY2023Period end 2023-03-31 | $5.26M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
